Picture EBD Group BioPharm America 2018 Boston September 600x60px
Document › Details

bioMérieux, Inc.. (8/21/14). "Press Release: ATCC and bioMérieux Collaborate to Deliver Accurate Identification of Industrial Microorganisms". Durham, NC & Manassas, VA.

Organisations Organisation bioMérieux Inc.
  Group Mérieux (Group)
  Organisation 2 ATCC (American Type Culture Collection)
Products Product VITEK® MS MALDI-TOF system
  Product 2 VITEK® MS database
Index terms Index term Mérieux–ATCC: mass spectrometry, 201408– collab expanding VITEK MS micro-organisms library using VITEK MS system at ATCC
  Index term 2 ATCC–Mérieux: mass spectrometer, 201408 supply recent acquisition of VITEK MS MALDI TOF system incl database by ATCC from bioMérieux
Persons Person Thiney, Pierre-Louis (Mérieux 201307 Executive Director US Industry at bioMérieux)
  Person 2 Baker, Tim (Baker & Yorke 201409 Partner)

Combined capabilities will enhance the accuracy and range of microbial identification for pharmaceutical, food, veterinary labs.

ATCC, the premier global biological materials resource and standards organization, and bioMérieux, a world leader in the field of in vitro diagnostics, announced today their collaboration to expand and solidify the bioMérieux VITEK® MS microbial identification database for the industrial market. Recently, ATCC acquired the bioMérieux VITEK® MS system to make this innovative MALDI TOF technology a fundamental component of their authentication and quality control processes.

Strengthening the database with additional strains continues to increase the robustness of the VITEK® MS micro-organisms library while increasing the size and enhancing the utility for customers as a solid quality assurance tool.

The integration of the bioMérieux VITEK® MS into ATCC's quality development process will enable ATCC to generate a large pathogen knowledgebase, which will then be incorporated into the VITEK® MS database. The newly expanded database will improve the accuracy and range of microbial identification of the bioMérieux VITEK® MS, a powerful pathogen identification solution for large industrial labs.

"For more than eight decades, Microbiology laboratories worldwide have looked to ATCC to provide well characterized microbial reference strains with the highest level of quality assurance," stated Kristina Peterman, Senior Director Compliance, Quality Assurance and Laboratory Testing Services/Chief Compliance Officer. "Utilizing the MALDI technology through the bioMérieux VITEK® MS system demonstrates our commitment to advancement, quality and innovation. The solution will also provide traceability and reduced testing time while reducing consumable costs in our extensive quality control process."

"We are delighted to partner with ATCC, the recognized expert in industrial microbial identifications, said Pierre-Louis Thiney, Executive Director US Industry for bioMérieux. The partnership exemplifies both companies commitment to quality standards for our food, pharmaceutical and veterinary customers. It truly is a testament to the strong added value of our VITEK® MS solution."

About ATCC

ATCC collaborates with and supports the scientific community with industry-standard products and innovative solutions. With the world's largest and most diverse collection of human, animal, and plant cell lines, as well as microorganisms, molecular genomic tools, and biological products, ATCC is a trusted biological resource for the worldwide research community. Together, the people of ATCC share in its mission to acquire, authenticate, preserve, develop, and distribute biological materials and information for the advancement of scientific knowledge. Founded in 1925, ATCC is a non-profit organization with headquarters in Manassas, VA. Discover more at

ATCC contact

Renée Randall
Tel: (703) 365-2773

About bioMérieux
Pioneering Diagnostics

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 41 subsidiaries and a large network of distributors. In 2013, revenues reached €1,588 million with 87% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM - ISIN: FR0010096479). Corporate website: - Investor website:


Media Relations

Suzanne Jones
Tel: +1 919.479.3637

Baker & Yorke
Tim Baker
Tel: + 1 216-338-8086

Aurore Sergeant
Tel.: + 33 4 78 87 38 66

Pascal Cruveiller
Tel.: + 33 4 78 87 50 19

Record changed: 2016-01-10


Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

More documents for Mérieux (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top